Buy Stocks Easy | About Us
September 28, 2021
Buy Stocks Easy | Online Stocks

ALRN


Buy Aileron Therapeutics, Inc. Stock (symbol: ALRN) Easy Online

Company Name: Aileron Therapeutics, Inc.

Symbol: ALRN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

ALRN Current Share Price

Today's ALRN ( Aileron Therapeutics, Inc. ) opening price: $0.5587

Yesterday's ALRN ( Aileron Therapeutics, Inc. ) closing price: $0.5650

Aileron Therapeutics, Inc. Stock ( symbol: ALRN ) Price Chart since IPO (2000):

12 Months Aileron Therapeutics, Inc. Stock ( symbol: ALRN ) Price Chart

Popular Questions about Aileron Therapeutics, Inc. Public Stock ( ALRN )

A: Aileron Therapeutics, Inc. stock symbol (also called stock or share ticker) is ALRN

A: Aileron Therapeutics, Inc. IPO (Initial Public Offering) took place on 2000

A: Aileron Therapeutics, Inc.'s stock (ALRN symbol) price at ther IPO (initial Public Offering) was $0.5587

Q: Is ALRN stock worth buying at the moment?

A: The ALRN stock performance since 2019 are rather disappointing. If you had bought 1 share of Aileron Therapeutics, Inc. stock (symbol: ALRN) at the beginning of 2019, at the opening share price of $1.1000, you would be left with exactly $0.5587 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Aileron Therapeutics, Inc. Stock Easy Online

Aileron Therapeutics, Inc. Stock Ticker Price Chart since IPO:





Aileron Therapeutics, Inc. Stock Price Yesterday



 


Aileron Therapeutics, Inc. Stock Price – Last Week




 


Aileron Therapeutics, Inc. Stock Price – Last Month




 


Aileron Therapeutics, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962186/0/en/Aileron-Therapeutics-Announces-the-Promotion-of-Richard-J-Wanstall-to-Chief-Financial-Officer-and-Treasurer.html
                            

                                
Aileron Therapeutics Announces the Promotion of Richard J. Wanstall  to Chief Financial Officer and Treasurer

                                
                                
WATERTOWN, Mass., Dec.  18, 2019  (GLOBE NEWSWIRE) -- Aileron Thera...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305032-aileron-therapeutics-inc-alrn-ceo-manuel-aivado-q3-2019-results-earnings-call-transcript
                            

                                
Aileron Therapeutics, Inc. (ALRN) CEO Manuel Aivado on Q3 2019 Results - Earnings Call Transcript

                                
                                
Aileron Therapeutics, Inc. (ALRN) CEO Manuel Aivado on Q3 2019 Resu...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/31/1938800/0/en/Aileron-Therapeutics-to-Report-Third-Quarter-2019-Financial-Results-on-November-7th.html
                            

                                
Aileron Therapeutics to Report Third Quarter 2019 Financial Results on November 7th

                                
                                
WATERTOWN, Mass., Oct.  31, 2019  (GLOBE NEWSWIRE) -- Aileron Thera...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936963/0/en/Aileron-Therapeutics-Announces-Positive-Nonclinical-Myelopreservation-Results-for-ALRN-6924-at-the-2019-AACR-NCI-EORTC-Conference.html
                            

                                
Aileron Therapeutics Announces Positive Nonclinical Myelopreservation Results for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference

                                
                                
Nonclinical research results show that ALRN-6924 prevented the toxi...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932491/0/en/Aileron-to-Present-Nonclinical-Myelopreservation-Data-for-ALRN-6924-at-the-2019-AACR-NCI-EORTC-Conference-on-October-29th.html
                            

                                
Aileron to Present Nonclinical Myelopreservation Data for ALRN-6924 at the 2019 AACR-NCI-EORTC Conference on October 29th

                                
                                
Nonclinical research showed that ALRN-6924 prevented the toxic side...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/16/1930507/0/en/Aileron-Therapeutics-Announces-the-Initiation-of-Patient-Treatment-in-its-First-Clinical-Ph1b-2-Trial-of-ALRN-6924-as-a-Myelopreservation-Agent.html
                            

                                
Aileron Therapeutics Announces the Initiation of Patient Treatment in its First Clinical Ph1b/2 Trial of ALRN-6924 as a Myelopreservation Agent

                                
                                
Treatment uses a precision-medicine strategy to prevent the toxic s...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/28/1922141/0/en/Aileron-Presents-Positive-Interim-Phase-2a-Data-for-ALRN-6924-in-Combination-with-Pfizer-s-Palbociclib-at-the-2019-Congress-of-the-European-Society-for-Medical-Oncology.html
                            

                                
Aileron Presents Positive Interim Phase 2a Data for ALRN-6924 in Combination with Pfizer’s Palbociclib at the 2019 Congress of the European Society for Medical Oncology

                                
                                
Final data expected in the second quarter of 2020 Final data expect...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1920320/0/en/Aileron-to-Present-Interim-Phase-2a-Clinical-Data-for-ALRN-6924-in-Combination-with-Pfizer-s-IBRANCE-palbociclib-in-Patients-with-MDM2-Amplified-Cancers-at-the-2019-Congress-of-the.html
                            

                                
Aileron to Present Interim Phase 2a Clinical Data for ALRN-6924 in Combination with Pfizer’s IBRANCE® (palbociclib) in Patients with MDM2-Amplified Cancers at the 2019 Congress of the European Society for Medical Oncology

                                
                                
WATERTOWN, Mass., Sept.  24, 2019  (GLOBE NEWSWIRE) -- Aileron Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1910432/0/en/Aileron-Therapeutics-to-Present-at-the-H-C-Wainwright-21st-Annual-Global-Investment-Conference-in-New-York.html
                            

                                
Aileron Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference in New York

                                
                                
WATERTOWN, Mass., Sept.  03, 2019  (GLOBE NEWSWIRE) -- Aileron Ther...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.